Medtronic Diabetes, Northridge, CA, USA.
Medtronic International Trading Sàrl, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
J Diabetes Sci Technol. 2024 Mar;18(2):454-459. doi: 10.1177/19322968221112120. Epub 2022 Jul 25.
Continuous subcutaneous insulin infusion (CSII, or insulin pump) and continuous glucose monitoring (CGM) sensors have been increasingly used and associated with improved glycemic control by people with type 1 diabetes and insulin-requiring type 2 diabetes. Commonly used infusion sets in most CSII systems are limited to a wear time of 3 days. In contradistinction, CGM sensors are currently approved for seven and more days of wear. With the motivation to provide a 7-day infusion set that matches the CGM wear time and to improve patient experience, the recently CE-marked and FDA 510k-cleared Medtronic extended infusion set (EIS) was designed.s The EIS offers enhanced new features that include use for up to 7 days, improved convenience, comfort, and better quality of life for insulin pump users.
持续皮下胰岛素输注（CSII，也称胰岛素泵）和连续血糖监测（CGM）传感器的应用越来越广泛，可改善 1 型糖尿病和需要胰岛素治疗的 2 型糖尿病患者的血糖控制。大多数 CSII 系统中常用的输注套件的佩戴时间限制为 3 天。相比之下，CGM 传感器目前的佩戴时间可长达 7 天或更长。为了提供与 CGM 佩戴时间相匹配的 7 天输注套件，并改善患者体验，美敦力公司最近获得 CE 标志和 FDA 510k 批准的延长输注套件（EIS）应运而生。EIS 提供了增强的新功能，包括长达 7 天的使用时间、提高便利性、舒适性以及改善胰岛素泵使用者的生活质量。
